RecallReported November 4, 2026
Class III recall by Meitheal Pharmaceuticals, Inc
Vecuronium Bromide for Injection, 20mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL. N…
FDA's enforcement report of November 4, 2026 lists a Class III recall by Meitheal Pharmaceuticals, Inc of Chicago, IL. Product: Vecuronium Bromide for Injection, 20mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL. N…. Status: Ongoing.
On the record
- Recalling firm
- Meitheal Pharmaceuticals, Inc
- Location
- Chicago, IL
- Classification
- Class III
- Status
- Ongoing
- Recall number
- D-0109-2027
- Product type
- Drugs
- Brand names
- VECURONIUM BROMIDE
- Generic names
- VECURONIUM BROMIDE
- Recall initiated
- 2026-10-08
- Reported by FDA
- 2026-11-04
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch Meitheal Pharmaceuticals, Inc
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Meitheal Pharmaceuticals, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.